[Skip to Content]

HS Talks - Experts' views on the Covid-19 pandemic

HSTalks logo

Henry Stewart Talks (HS Talks) has released four additional interviews on the Covid-19 pandemic in The Biomedical & Life Sciences Collection. These interviews and others are published Open Access and are accessible through the Library website.

Interferon-α2b as a therapy for COVID-19
Prof. Eleanor N. Fish, University of Toronto, Canada

Prof. Eleanor Fish from the Department of Immunology at the University of Toronto speaks about the use of Interferon-α2b treatment for COVID-19, including the importance of properly timing the treatment, modes of administration and potential use in combination with other therapies.

Imperial College London's saRNA Vaccine - COVAC1

Dr. Katrina Pollock, Imperial College London, UK

Dr. Katrina Pollock, Chief Investigator for the Imperial COVID-19 RNA vaccine trials and Principle Investigator for the Oxford COVID-19 vaccine trials, discusses the saRNA Vaccine COVAC1 currently being developed at Imperial College London. The interview covers the molecular basis of the self-amplifying RNA vaccine technology being used, an update on the clinical trial and the future of the vaccine as it currently stands.

Potential long-term health effects of a SARS-CoV-2 infection
Prof. Danny Altmann, Imperial College London, UK

Prof. Danny Altmann of Imperial College London delves into the current knowledge of the potential long-term health effects of the SARS-CoV-2 infection, including current hypotheses regarding the cause of these effects and parallels with other viral infections.

The neurological symptoms of COVID-19Dr. Michael Zandi, University College London, UK

Finally, Prof. Michael Zandi of the Institute of Neurology at UCL provides an account of the range of neurological symptoms and psychiatric complications reported in subgroups of Covid-19 patients and suggests possible mechanisms that may underly them.